| Exposed | Controls | OR | CI95% | p-value |
Hearing loss |
|
|
|
|
|
No | 32 (58.2%) | 51 (92.7%) | 1 |
|
|
Yes | 23 (41.8%) | 4 (7.3%) | 9.16 | [3.18 - 33.5] | <0.001* |
Tinnitus |
|
|
|
|
|
No | 44 (80.0%) | 47 (85.5%) | 1 |
|
|
Yes | 11 (20.0%) | 8 (14.6%) | 1.47 | [0.54 - 4.12] | 0.449* |
Vertigo |
|
|
|
|
|
No | 54 (98.2%) | 55 (100%) | - | - |
|
Yes | 1 (1.8%) | 0 (0.0%) | - | - | 1.000** |
Otalgia |
|
|
|
|
|
No | 53 (96.4%) | 55 (100.0%) | - |
|
|
Yes | 2 (3.6%) | 0 (0.0%) | - | - | 0.495** |
Otorrhea |
|
|
|
|
|
No | 54 (98.2%) | 55 (100.0%) |
|
|
|
Oui | 1 (1.8%) | 0 (0.0%) | - | - | 1.000** |
Headache |
|
| - | - |
|
No | 51 (92.7%) | 55 (100.0%) | - | - |
|
Yes | 4 (7.3%) | 0 (0.0%) | - | - | 0.118** |